Safe use of Opioid

XMLWordPrintable

    • Type: Hosp Inpt eCQMs - Hospital Inpatient eCQMs
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Hide
      Thank you for your question regarding CMS506v7, Safe Use of Opioids - Concurrent Prescribing. For Reporting Year 2025, the specifications for CMS506v7 should be used. This covers the measurement period of January 1, 2025 through December 31, 2025. For Reporting Year 2026, the specifications for CMS506v8 should be used which covers the measurement period of January 1, 2026 through December 31, 2026.
      Show
      Thank you for your question regarding CMS506v7, Safe Use of Opioids - Concurrent Prescribing. For Reporting Year 2025, the specifications for CMS506v7 should be used. This covers the measurement period of January 1, 2025 through December 31, 2025. For Reporting Year 2026, the specifications for CMS506v8 should be used which covers the measurement period of January 1, 2026 through December 31, 2026.
    • CMS0506v8
    • CMS0506v7
    • The measure is not counting the accounts accurately

      Hello, 

      For RY 2025, CMS 506 specification has the exclusions for the patient receiving medication for opioid use disorder. For RY 2026 the specification changes to patient receiving medication for opioid use disorder with active OUD diagnosis or MAT. However, the current logic is not allowing to consider the medication only for OUD as an exclusion. Please let us know how we can capture the accurate data with the 2026 specification under reporting year 2025? thank you. 

            Assignee:
            Mathematica EH eCQM Team
            Reporter:
            Mudrabahen Patel
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: